Compromised Dynamic Cerebral Autoregulation in Patients with Restless Legs Syndrome

References

• Gossard TR, Trotti LM, Videnovic A, et al. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics. 2021;18(1):140–155. doi:10.1007/s13311-021-01019-4
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Allen R, Högl B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018;17(11):994–1005. doi:10.1016/S1474-4422(18)30311-9
   PubMed Web of Science ®Google Scholar
• Katsanos AH, Kosmidou M, Konitsiotis S, et al. Restless legs syndrome and cerebrovascular/cardiovascular events: systematic review and meta-analysis. Acta Neurol Scand. 2018;137(1):142–148. doi:10.1111/ane.12848
   PubMed Web of Science ®Google Scholar
• Byun JI, Jung KY, Lee GT, et al. Spontaneous low-frequency cerebral hemodynamics oscillations in restless legs syndrome with periodic limb movements during sleep: a near-infrared spectroscopy study. J Clin Neurol. 2016;12(1):107–114. doi:10.3988/jcn.2016.12.1.107
   PubMed Web of Science ®Google Scholar
• Cho JW, Duffy JF. Sleep, sleep disorders, and sexual dysfunction. World J Mens Health. 2019;37(3):261–275. doi:10.5534/wjmh.180045
   PubMedGoogle Scholar
• Gao X, Schwarzschild MA, O’Reilly EJ, et al. Restless legs syndrome and erectile dysfunction. Sleep. 2010;33(1):75–79. doi:10.1093/sleep/33.1.75
   PubMed Web of Science ®Google Scholar
• Shneyder N, Adler CH, Hentz JG, et al. Autonomic complaints in patients with restless legs syndrome. Sleep Med. 2013;14(12):1413–1416. doi:10.1016/j.sleep.2013.08.781
   PubMed Web of Science ®Google Scholar
• Kim MS, Park DG, Yoon JH. Impaired endothelial function may predict treatment response in restless legs syndrome. J Neural Transm. 2019;126(8):1051–1059. doi:10.1007/s00702-019-02031-x
   PubMed Web of Science ®Google Scholar
• Chenini S, Rassu AL, Guiraud L, et al. Blood pressure profile and endothelial function in restless legs syndrome. Sci Rep. 2019;9(1):15933. doi:10.1038/s41598-019-52401-4
   PubMedGoogle Scholar
• Patton SM, Ponnuru P, Snyder AM, et al. Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol. 2011;18(11):1329–1335. doi:10.1111/j.1468-1331.2011.03397.x
   PubMed Web of Science ®Google Scholar
• Baskol G, Korkmaz S, Erdem F, et al. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med. 2012;13(4):414–418. doi:10.1016/j.sleep.2011.11.012
   PubMed Web of Science ®Google Scholar
• Aries MJ, Elting JW, De Keyser J, et al. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke. 2010;41(11):2697–2704. doi:10.1161/STROKEAHA.110.594168
   PubMed Web of Science ®Google Scholar
• Claassen JA, Meel-van den Abeelen AS, Simpson DM, et al. International Cerebral Autoregulation Research Network (CARNet). Transfer function analysis of dynamic cerebral autoregulation: a white paper from the International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab. 2016;36(4):665–680. doi:10.1177/0271678X15626425
   PubMed Web of Science ®Google Scholar
• Qu Y, Zhang P, He QY, et al. The impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and brain injury related biomarkers. Front Physiol. 2022;13:835173. doi:10.3389/fphys.2022.835173
   PubMed Web of Science ®Google Scholar
• Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med. 2009;266(5):419–431. doi:10.1111/j.1365-2796.2009.02159.x
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Armstrong MJ, Allen RP, et al. Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2016;87(24):2585–2593. doi:10.1212/WNL.0000000000003388
   PubMed Web of Science ®Google Scholar
• Partinen M, Hirvonen K, Jama L, et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study – the PRELUDE study. Sleep Med. 2006;7(5):407–417. doi:10.1016/j.sleep.2006.03.011
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006;67(6):1034–1039. doi:10.1212/01.wnl.0000231513.23919.a1
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Stiasny-Kolster K, Kupsch A, et al. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord. 2006;21(9):1404–1410. doi:10.1002/mds.20983
   PubMed Web of Science ®Google Scholar
• Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6(1):108–113. doi:10.1016/j.coph.2005.11.003
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59(10):1573–1579. doi:10.1212/WNL.59.10.1573
   PubMed Web of Science ®Google Scholar
• Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca (2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 2002;42(2):229–236. doi:10.1016/S0028-3908(01)00172-1
   PubMed Web of Science ®Google Scholar
• Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, and significance. Sleep Med. 2014;15(8):860–873. doi:10.1016/j.sleep.2014.03.025
   PubMed Web of Science ®Google Scholar
• Wijemanne S, Jankovic J. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Med. 2015;16(6):678–690. doi:10.1016/j.sleep.2015.03.002
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Hening WA, Montagna P, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008;23(16):2267–2302. doi:10.1002/mds.22254
   PubMed Web of Science ®Google Scholar
• Allen RP, Burchell BJ, MacDonald B, et al. Validation of the self-completed Cambridge–Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med. 2009;10(10):1097–1100. doi:10.1016/j.sleep.2008.10.007
   PubMed Web of Science ®Google Scholar
• Abetz L, Arbuckle R, Allen RP, et al. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical trial setting. Sleep Med. 2006;7(4):340–349. doi:10.1016/j.sleep.2005.12.011
   PubMed Web of Science ®Google Scholar
• Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132.
   PubMed Web of Science ®Google Scholar
• van Beek AH, Claassen JA, Rikkert MG, et al. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071–1085. doi:10.1038/jcbfm.2008.13
   PubMed Web of Science ®Google Scholar
• van Beek AH, Claassen JA, Rikkert MG, et al. Frequency domain analysis of cerebral blood flow velocity and its correlation with arterial blood pressure. J Cereb Blood Flow Metab. 1998;18(3):311–318. doi:10.1097/00004647-199803000-00010
   PubMed Web of Science ®Google Scholar
• San Pedro EC, Mountz JM, Mountz JD, et al. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus. J Rheumatol. 1998;25(11):2270–2275.
   PubMed Web of Science ®Google Scholar
• Chenini S, Barateau L, Rassu AL, et al. Systematic assessment of autonomic symptoms in restless legs syndrome. Sleep Med. 2021;80:30–38. doi:10.1016/j.sleep.2021.01.017
   PubMed Web of Science ®Google Scholar
• Izzi F, Placidi F, Romigi A, et al. Is autonomic nervous system involved in restless legs syndrome during wakefulness? Sleep Med. 2014;15(11):1392–1397. doi:10.1016/j.sleep.2014.06.022
   PubMed Web of Science ®Google Scholar
• Ferri R, Zucconi M, Rundo F, et al. Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep. Clin Neurophysiol. 2007;118(2):438–448. doi:10.1016/j.clinph.2006.10.007
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–65. doi:10.1002/mds.870120111
   PubMed Web of Science ®Google Scholar
• Hamner JW, Tan CO. Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke. 2014;45(6):1771–1777. doi:10.1161/STROKEAHA.114.005293
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Redline S, Baldwin CM, et al. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the sleep heart health study. Sleep. 2009;32(6):772–778.
   PubMed Web of Science ®Google Scholar
• Hornyak M, Feige B, Voderholzer U, et al. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep. 2007;30(7):861–865. doi:10.1093/sleep/30.7.861
   PubMed Web of Science ®Google Scholar
• Stang A, Moebus S, Möhlenkamp S, et al. Gender-specific associations of short sleep duration with prevalent hypertension. Hypertension. 2008;51(3):e15–e16. doi:10.1161/HYPERTENSIONAHA.107.108456
   PubMed Web of Science ®Google Scholar
• Kowall B, Lehnich AT, Strucksberg KH, et al. Associations among sleep disturbances, nocturnal sleep duration, daytime napping, and incident prediabetes and type 2 diabetes: the Heinz Nixdorf recall study. Sleep Med. 2016;21:35–41. doi:10.1016/j.sleep.2015.12.017
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, D’Elia L, Strazzullo P, et al. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414–420. doi:10.2337/dc09-1124
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Cooper D, D’Elia L, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–1492. doi:10.1093/eurheartj/ehr007
   PubMed Web of Science ®Google Scholar
• Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3(5):489–494. doi:10.5664/jcsm.26913
   PubMed Web of Science ®Google Scholar
• Chandola T, Ferrie JE, Perski A, et al. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep. 2010;33(6):739–744. doi:10.1093/sleep/33.6.739
   PubMed Web of Science ®Google Scholar
• Carreras A, Zhang SX, Peris E, et al. Chronic sleep fragmentation induces endothelial dysfunction and structural vascular changes in mice. Sleep. 2014;37(11):1817–1824. doi:10.5665/sleep.4178
   PubMed Web of Science ®Google Scholar
• Clark AJ, Salo P, Lange T, et al. Onset of impaired sleep and cardiovascular disease risk factors: a longitudinal study. Sleep. 2016;39(9):1709–1718. doi:10.5665/sleep.6098
   PubMed Web of Science ®Google Scholar
• Bassetti CL, Aldrich MS. Sleep electroencephalogram changes in acute hemispheric stroke. Sleep Med. 2001;2(3):185–194. doi:10.1016/S1389-9457(00)00071-X
   PubMed Web of Science ®Google Scholar
• Gottselig JM, Bassetti CL, Achermann P. Power and coherence of sleep spindle frequency activity following hemispheric stroke. Brain. 2002;125(Pt 2):373–383. doi:10.1093/brain/awf021
   PubMed Web of Science ®Google Scholar
• Green DJ, Dawson EA, Groenewoud HM, et al. Is flow-mediated dilation nitric oxide mediated? A meta-analysis. Hypertension. 2014;63(2):376–382. doi:10.1161/HYPERTENSIONAHA.113.02044
   PubMed Web of Science ®Google Scholar
• Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673–2678. doi:10.1161/hc4601.099485
   PubMed Web of Science ®Google Scholar
• Daiber A, Steven S, Weber A, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–1619. doi:10.1111/bph.13517
   PubMed Web of Science ®Google Scholar
• Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr. 2003;23(1):41–58. doi:10.1146/annurev.nutr.23.020102.075739
   PubMedGoogle Scholar
• Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698–1700. doi:10.1212/WNL.54.8.1698
   PubMed Web of Science ®Google Scholar
• Earley CJ, Connor JR, Beard JL, et al. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep. 2005;28(9):1069–1075. doi:10.1093/sleep/28.9.1069
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6(6):337–346. doi:10.1038/nrneurol.2010.55
   PubMed Web of Science ®Google Scholar
• Martens M, McConnell FK, Filippini N, et al. Dopaminergic modulation of regional cerebral blood flow: an arterial spin labelling study of genetic and pharmacological manipulation of COMT activity. Neuroimage. 2021;234:117999. doi:10.1016/j.neuroimage.2021.117999
   PubMed Web of Science ®Google Scholar
• Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132(Pt9):2403–2412. doi:10.1093/brain/awp125
   PubMedGoogle Scholar
• Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125–130. doi:10.1212/01.wnl.0000223316.53428.c9
   PubMed Web of Science ®Google Scholar
• Högl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med. 2011;12(4):351–360. doi:10.1016/j.sleep.2010.12.007
   PubMed Web of Science ®Google Scholar
• Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol. 1997;20(2):148–151. doi:10.1097/00002826-199704000-00006
   PubMed Web of Science ®Google Scholar
• Pugsley TA, Whetzel SZ, Dooley DJ. Reduction of 3,4-diaminopyridine-induced biogenic amine synthesis and release in rat brain by gabapentin. Psychopharmacology. 1998;137(1):74–80. doi:10.1007/s002130050595
   PubMed Web of Science ®Google Scholar